StockNews.com began coverage on shares of InspireMD (NYSE:NSPR – Free Report) in a research report sent to investors on Thursday. The firm issued a sell rating on the stock.
InspireMD Trading Down 0.5 %
NSPR stock opened at $2.00 on Thursday. The company’s 50 day moving average is $2.30 and its 200 day moving average is $2.62. The stock has a market cap of $46.80 million, a price-to-earnings ratio of -1.85 and a beta of 0.92. InspireMD has a 1-year low of $1.29 and a 1-year high of $3.85.
InspireMD (NYSE:NSPR – Get Free Report) last posted its quarterly earnings results on Wednesday, March 6th. The company reported ($0.16) earnings per share for the quarter, topping the consensus estimate of ($0.20) by $0.04. InspireMD had a negative net margin of 320.97% and a negative return on equity of 55.71%. The business had revenue of $1.76 million during the quarter, compared to the consensus estimate of $1.65 million. During the same period in the previous year, the firm posted ($0.60) earnings per share. As a group, sell-side analysts forecast that InspireMD will post -0.61 EPS for the current fiscal year.
Institutional Investors Weigh In On InspireMD
About InspireMD
InspireMD, Inc, a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions.
Featured Stories
- Five stocks we like better than InspireMD
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- MarketBeat Week in Review – 4/29 – 5/3
- What to Know About Investing in Penny Stocks
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- How to Use the MarketBeat Dividend Calculator
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.